A multi-center, open-label study to evaluate the safety and efficacy of a consecutive treatment regimen of clobetasol propionate 0.05 percent spray, followed by calcitriol ointment 3microg/g, in the management of moderate to severe plaque psoriasis

Trial Profile

A multi-center, open-label study to evaluate the safety and efficacy of a consecutive treatment regimen of clobetasol propionate 0.05 percent spray, followed by calcitriol ointment 3microg/g, in the management of moderate to severe plaque psoriasis

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Oct 2014

At a glance

  • Drugs Calcitriol; Clobetasol
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Galderma
  • Most Recent Events

    • 01 Sep 2009 Status changed from active, no longer recruiting to completed.
    • 22 Dec 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 05 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top